The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer

Yuen Yee Cheng, 1, 2 Emma M Rath, 3 Anthony Linton, 1, 2, 4 Man Lee Yuen, 1 Ken Takahashi, 1 Kenneth Lee 1, 2, 4  1Asbestos Disease Research Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; 2Sydney Medical School, The University of Sydney...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Cheng YY, Rath EM, Linton A, Yuen ML, Takahashi K, Lee K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	lung cancer epigenetic biomarkers microrna dna methylation immunohistochemistry (ihc) fluorescence in situ hybridization (fish). Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/54c46ada77a346afbda5bc2c065dab8a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:54c46ada77a346afbda5bc2c065dab8a
record_format	dspace
spelling	oai:doaj.org-article:54c46ada77a346afbda5bc2c065dab8a2021-12-02T08:01:16ZThe Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer1179-2728https://doaj.org/article/54c46ada77a346afbda5bc2c065dab8a2020-01-01T00:00:00Zhttps://www.dovepress.com/the-current-understanding-of-asbestos-induced-epigenetic-changes-assoc-peer-reviewed-article-LCTThttps://doaj.org/toc/1179-2728Yuen Yee Cheng, 1, 2 Emma M Rath, 3 Anthony Linton, 1, 2, 4 Man Lee Yuen, 1 Ken Takahashi, 1 Kenneth Lee 1, 2, 4  1Asbestos Disease Research Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; 2Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; 4Concord Repatriation General Hospital, Sydney, New South Wales, AustraliaCorrespondence: Yuen Yee ChengAsbestos Disease Research Institute, PO Box 3628, Rhodes, New South Wales 2139, AustraliaTel +61 2 9767 9800Fax +61 2 9767 9860Email yycheng@adri.org.auAbstract: Asbestos is a naturally occurring mineral consisting of extremely fine fibres that can become trapped in the lungs after inhalation. Occupational and environmental exposures to asbestos are linked to development of lung cancer and malignant mesothelioma, a cancer of the lining surrounding the lung. This review discusses the factors that are making asbestos-induced lung cancer a continuing problem, including the extensive historic use of asbestos and decades long latency between exposure and disease development. Genomic mutations of DNA nucleotides and gene rearrangements driving lung cancer are well-studied, with biomarkers and targeted therapies already in clinical use for some of these mutations. The genes involved in these mutation biomarkers and targeted therapies are also involved in epigenetic mechanisms and are discussed in this review as it is hoped that identification of epigenetic aberrations in these genes will enable the same gene biomarkers and targeted therapies to be used. Currently, understanding of how asbestos fibres trapped in the lungs leads to epigenetic changes and lung cancer is incomplete. It has been shown that oxidoreduction reactions on fibre surfaces generate reactive oxygen species (ROS) which in turn damage DNA, leading to genetic and epigenetic alterations that reduce the activity of tumour suppressor genes. Epigenetic DNA methylation changes associated with lung cancer are summarised in this review, and some of these changes will be due to asbestos exposure. So far, little research has been carried out to separate the asbestos driven epigenetic changes from those due to non-asbestos causes of lung cancer. Asbestos-associated lung cancers exhibit less methylation variability than lung cancers in general, and in a large proportion of samples variability has been found to be restricted to promoter regions. Epigenetic aberrations in cancer are proving to be promising biomarkers for diagnosing cancers. It is hoped that further understanding of epigenetic changes in lung cancer can result in useful asbestos-associated lung cancer biomarkers to guide treatment. Research is ongoing into the detection of lung cancer epigenetic alterations using non-invasive samples of blood and sputum. These efforts hold the promise of non-invasive cancer diagnosis in the future. Efforts to reverse epigenetic aberrations in lung cancer by epigenetic therapies are ongoing but have not yet yielded success.Keywords: lung cancer, epigenetic biomarkers, microRNA, DNA methylation, immunohistochemistry, IHC, fluorescence in situ hybridization, FISHCheng YYRath EMLinton AYuen MLTakahashi KLee KDove Medical Pressarticlelung cancerepigenetic biomarkersmicrornadna methylationimmunohistochemistry (ihc)fluorescence in situ hybridization (fish).Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol Volume 11, Pp 1-11 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	lung cancer epigenetic biomarkers microrna dna methylation immunohistochemistry (ihc) fluorescence in situ hybridization (fish). Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	lung cancer epigenetic biomarkers microrna dna methylation immunohistochemistry (ihc) fluorescence in situ hybridization (fish). Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Cheng YY Rath EM Linton A Yuen ML Takahashi K Lee K The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
description	Yuen Yee Cheng, 1, 2 Emma M Rath, 3 Anthony Linton, 1, 2, 4 Man Lee Yuen, 1 Ken Takahashi, 1 Kenneth Lee 1, 2, 4  1Asbestos Disease Research Institute, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia; 2Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; 3Garvan Institute of Medical Research, Sydney, New South Wales, Australia; 4Concord Repatriation General Hospital, Sydney, New South Wales, AustraliaCorrespondence: Yuen Yee ChengAsbestos Disease Research Institute, PO Box 3628, Rhodes, New South Wales 2139, AustraliaTel +61 2 9767 9800Fax +61 2 9767 9860Email yycheng@adri.org.auAbstract: Asbestos is a naturally occurring mineral consisting of extremely fine fibres that can become trapped in the lungs after inhalation. Occupational and environmental exposures to asbestos are linked to development of lung cancer and malignant mesothelioma, a cancer of the lining surrounding the lung. This review discusses the factors that are making asbestos-induced lung cancer a continuing problem, including the extensive historic use of asbestos and decades long latency between exposure and disease development. Genomic mutations of DNA nucleotides and gene rearrangements driving lung cancer are well-studied, with biomarkers and targeted therapies already in clinical use for some of these mutations. The genes involved in these mutation biomarkers and targeted therapies are also involved in epigenetic mechanisms and are discussed in this review as it is hoped that identification of epigenetic aberrations in these genes will enable the same gene biomarkers and targeted therapies to be used. Currently, understanding of how asbestos fibres trapped in the lungs leads to epigenetic changes and lung cancer is incomplete. It has been shown that oxidoreduction reactions on fibre surfaces generate reactive oxygen species (ROS) which in turn damage DNA, leading to genetic and epigenetic alterations that reduce the activity of tumour suppressor genes. Epigenetic DNA methylation changes associated with lung cancer are summarised in this review, and some of these changes will be due to asbestos exposure. So far, little research has been carried out to separate the asbestos driven epigenetic changes from those due to non-asbestos causes of lung cancer. Asbestos-associated lung cancers exhibit less methylation variability than lung cancers in general, and in a large proportion of samples variability has been found to be restricted to promoter regions. Epigenetic aberrations in cancer are proving to be promising biomarkers for diagnosing cancers. It is hoped that further understanding of epigenetic changes in lung cancer can result in useful asbestos-associated lung cancer biomarkers to guide treatment. Research is ongoing into the detection of lung cancer epigenetic alterations using non-invasive samples of blood and sputum. These efforts hold the promise of non-invasive cancer diagnosis in the future. Efforts to reverse epigenetic aberrations in lung cancer by epigenetic therapies are ongoing but have not yet yielded success.Keywords: lung cancer, epigenetic biomarkers, microRNA, DNA methylation, immunohistochemistry, IHC, fluorescence in situ hybridization, FISH
format	article
author	Cheng YY Rath EM Linton A Yuen ML Takahashi K Lee K
author_facet	Cheng YY Rath EM Linton A Yuen ML Takahashi K Lee K
author_sort	Cheng YY
title	The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
title_short	The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
title_full	The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
title_fullStr	The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
title_full_unstemmed	The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer
title_sort	current understanding of asbestos-induced epigenetic changes associated with lung cancer
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/54c46ada77a346afbda5bc2c065dab8a
work_keys_str_mv	AT chengyy thecurrentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT rathem thecurrentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT lintona thecurrentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT yuenml thecurrentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT takahashik thecurrentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT leek thecurrentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT chengyy currentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT rathem currentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT lintona currentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT yuenml currentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT takahashik currentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer AT leek currentunderstandingofasbestosinducedepigeneticchangesassociatedwithlungcancer
_version_	1718398722149187584

The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer

Ejemplares similares